N/A N=65 Return of First-phase Insulin Secretion in Type 2 Diabetes is Associated With Depletion of Pancreas Lipid
Type 2 Diabetes Mellitus
Primary: Changes in Liver Fat — 5.4; 7.3 percent liver fat — p=0.05
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=17 Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome
HIV Lipodystrophy
Primary: Rate of Total Lipolysis — 0.649; 0.767 mmol FFA/kg/h
N/A N=106 Lipid Metabolism in Gestational Diabetes
Gestational Diabetes · Hyperlipidemia
Primary: Cholesterol — 204; 201 mg/dl
N/A N=60 Inhibition of Lipid Peroxidation During Cardiac Surgery
Cardiopulmonary Bypass Induced Lipid Peroxidation
Primary: Plasma Isofuran Concentrations — 61.5; 67.7; 72.1; 82.7 pg/mL — p=0.05
Phase 4 N=87 Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Coronary Artery Disease
Primary: Lipiscan - Lipid Core Burden Index (LCBI) — 95.4; 132.4; 99.9; 99.8 ratio
Phase 2 N=475 Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease
Cardiovascular Disease · Hypertension · Hyperlipidemia
Primary: Systolic Blood Pressure — 121.7; 129.7 mm Hg
Phase 4 N=303 Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
Obstruction · Cancer · Ileus
Primary: Prealbumin — 0.15; 0.16 g/l
N/A N=15 Evaluation of Lipid Emulsion on GCX in Critically Ill Patients
Endothelial Dysfunction
Primary: Endothelial Glycocalyx Thickness — 2.28 micrometer
N/A N=720 Effect of an Atlantic Diet on Anthropometric Indices and Serum Lipid Profile
Cardiovascular Disease · Adiposity · Hypercholesterolemia
Primary: Changes in Total-cholesterol Levels — -6.9; -0.6 mg/dl
N/A N=48 An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery
Morbid Obesity
Primary: Triglycerides Post-prandial — 95; 71; 134 mmol/L
Phase 2 N=91 YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
Obstructive Coronary Artery Disease · Coronary Artery Disease
Primary: Correlation Between Plaque Morphology and HDL Functionality — 0.30 beta coefficient
N/A N=68 The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism
Atherosclerosis · Low-density Lipoproteins Aggregation Susceptibility · Low-density Lipoprotein Lipid Composition
Primary: LDL Aggregation Susceptibility — 111.3; 113.1 Minutes
Phase 3 N=48 Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates
Cholestasis of Parenteral Nutrition
Primary: Number of Participants With Cholestasis — 1; 3; 7 Participants — p=0.590
N/A N=25 Mechanisms of Insulin Resistance in Humans
Inflammation · Insulin Resistance
Primary: Insulin Signaling With Lipid Infusion — 0.4334; 0.7276; 0.5264; 0.3534 ratio
Phase 3 N=21 Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
Cholestasis
Primary: Rate of Rise of Direct Bilirubin as a Function of Time — 1.033001353; 1.05457485; 1.025504411; 1.049318179 mg/dL/day